These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2263025)

  • 1. [Steroid withdrawal in renal transplant recipients].
    Nakamura H; Murai M; Asano T; Takao M; Yoshizawa N; Sekiguchi S
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1033-7. PubMed ID: 2263025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation.
    van de Wetering J; Gerrits JH; van Besouw NM; Ijzermans JN; Weimar W
    Transplantation; 2009 Mar; 87(5):740-4. PubMed ID: 19295320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I; Reisman L; Lieberman KV; Burrows L
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal of steroid immunosuppression in renal transplant recipients.
    Stratta RJ; Armbrust MJ; Oh CS; Pirsch JD; Kalayoglu M; Sollinger HW; Belzer FO
    Transplantation; 1988 Feb; 45(2):323-8. PubMed ID: 3278423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
    Hamiwka LA; Burns A; Bell L
    Pediatr Transplant; 2006 May; 10(3):337-44. PubMed ID: 16677358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
    Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P
    J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.
    Nart A; Sipahi S; Aykas A; Uslu A; Hoşcoşkun C; Toz H
    Transplant Proc; 2008; 40(1):189-92. PubMed ID: 18261583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity.
    Klaus G; Jeck N; Konrad M; Förster B; Soergel M
    Clin Nephrol; 2001 Dec; 56(6):S37-42. PubMed ID: 11770812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful steroid withdrawal after long-term administration in renal transplant patients.
    Amada N; Kikuchi H; Haga I; Fukumori T; Sato A; Sato T
    Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful withdrawal of corticosteroids in heart transplantation.
    Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
    J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
    Hricik DE; Seliga RM; Fleming-Brooks S; Bartucci MR; Schulak JA
    Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.